Matrix metalloproteinases and their tissue inhibitors - expression, role and regulation in human malignant non-Hodgkin's lymphomas

Leukemia & Lymphoma
A E KossakowskaA Janowska-Wieczorek

Abstract

Human malignant non-Hodgkin's lymphomas (NHL) represent a heterogeneous group of neoplasms, which vary in their clinical behavior and pathophysiology. Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) have been shown to play a role in the pathophysiology and clinical aggressiveness of human NHL. In this setting, MMP-9 and TIMP-1 appear to be the most important members of the MMP and TIMP families, and overexpression of both correlates with a poor clinical outcome of patients with NHL. MMP-9 and TIMP-1, however, act through different mechanisms and are produced by different cell types. Expression of both is upregulated by interleukin-6 (IL-6), a cytokine that is known as one of the factors involved in the pathophysiology of human NHL. In this review we summarize the complex regulation of MMP and TIMP expression in human NHL and propose a mechanism by which MMP-9, TIMP-1 and IL-6 may influence the biology of these tumors.

References

Jul 1, 1992·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L M Matrisian
Sep 1, 1991·The American Journal of the Medical Sciences·C L MainardiK A Hasty
Dec 1, 1990·Cancer Metastasis Reviews·W G Stetler-Stevenson
Nov 1, 1995·The Journal of Clinical Investigation·S LacrazJ M Dayer
Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J F SeymourR Kurzrock
Jan 1, 1993·Clinical Oncology : a Journal of the Royal College of Radiologists·C A BaughanR M Pickering
Jan 1, 1993·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·H Birkedal-HansenJ A Engler
Apr 16, 1993·Biochimica Et Biophysica Acta·A M MontgomeryR A Reisfeld
Jun 6, 1993·Biochimica Et Biophysica Acta·H ZhouP C Billings
Jul 1, 1996·The Journal of Urology·P Hanno
Jun 1, 1996·Seminars in Cancer Biology·W G Stetler-StevensonM Corcoran
Dec 1, 1995·Cancer Metastasis Reviews·A F ChambersA C Groom
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·S KoopA C Groom
Jan 1, 1997·European Journal of Pediatrics·C KrügerH Herkenhoff
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·A Matsuzaki, A Janowska-Wieczorek
Mar 28, 1997·International Journal of Cancer. Journal International Du Cancer·F AoudjitY St-Pierre
Jan 1, 1996·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·J A MadriT Haas
Jan 1, 1996·Critical Reviews in Oncogenesis·L GuedezW G Stetler-Stevenson
Jul 1, 1997·Leukemia & Lymphoma·J Cortes, R Kurzrock
Feb 14, 1998·International Journal of Cancer. Journal International Du Cancer·P ValenteA Albini
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·T YoshizakiJ S Pagano
Jun 30, 1998·European Journal of Immunology·N Di GirolamoD Wakefield
Jun 30, 1998·Journal of Cancer Research and Clinical Oncology·G SawickiA Janowska-Wieczorek
Dec 3, 1998·The Journal of Clinical Investigation·L GuedezM Stetler-Stevenson
Feb 13, 1999·International Journal of Cancer. Journal International Du Cancer·K McCarthyM J Duffy
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·P HenrietY A Declerck
Jul 17, 1999·British Journal of Cancer·M N Holten-AndersenR W Stephens
Jul 23, 1999·Annals of the New York Academy of Sciences·W BodeK Maskos
Jul 23, 1999·Annals of the New York Academy of Sciences·L BlavierY A Declerck
Jul 23, 1999·Annals of the New York Academy of Sciences·M S LimM Stetler-Stevenson
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·F AoudjitY St-Pierre

❮ Previous
Next ❯

Citations

Jun 10, 2004·Pathology Oncology Research : POR·Anna CsiszárEva Pócsik
May 16, 2006·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Yanxia ZhaoHanying Sun
Feb 13, 2001·Leukemia Research·O KuittinenT Turpeenniemi-Hujanen
Jan 9, 2008·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Takashi MatsumotoMorio Koike
Jan 22, 2008·Pathology, Research and Practice·Elvan Caglar CitakNalan Akyurek
Apr 2, 2004·International Journal of Clinical Practice·B HazarN Tiftik
Oct 25, 2011·International Journal of Cancer. Journal International Du Cancer·Lan-Ping DiaoYu-Huan Gao
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jennifer L OwenDiana M Lopez
Sep 10, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Céline Van ThemscheYves St-Pierre
Jul 9, 2003·The Journal of Biological Chemistry·Josiane SancéauBrigitte Bauvois
Jan 15, 2020·Analytical Cellular Pathology (Amsterdam)·Alexandra Ioana CioroianuFlorica Staniceanu
Oct 24, 2020·Cancer Gene Therapy·Cinzia GiagulliArnaldo Caruso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.